Linden Capital Partners Majority Recapitalizes BioIVT from Arsenal Capital Partners

Berkshire Partners and Leonard Green Join Linden in Strategic Investment in Vital Care

August 1, 2024

Healthcare Services

Vital Care, a Brentwood, Tennessee-based franchisor of infusion therapy pharmacies with more than 160 locations, received a strategic investment from Berkshire Partners and Leonard Green & Partners alongside existing investor Linden Capital Partners. The capital will support franchisee reinvestment, operational enhancements, and continued expansion to increase access to infusion therapy across the U.S.; financial terms were not disclosed.

Linden Capital Partners Makes Majority Investment in Aptitude Health

April 26, 2021

Healthcare Services

Linden Capital Partners will make a majority investment in Aptitude Health alongside the company's founder and management team. Aptitude Health, an Atlanta-based provider of market insights and strategic solutions for oncology and hematology, will partner with Linden to accelerate growth and expand its service offerings; the transaction was expected to close in May 2021.

Linden Capital Partners Takes Majority Stake in Vital Care

October 19, 2020

Healthcare Services

Linden Capital Partners, a Chicago-based healthcare private equity firm, announced a majority investment in Vital Care, Inc., the Meridian, Mississippi franchisor of home infusion services. The transaction was completed alongside current shareholders (the Bell family) and management, with Linden positioning to support growth of the franchise system through healthcare-focused operating expertise and capital.

IK Partners Acquires Majority Stake in BIOBank

May 29, 2024

Medical Devices

IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.

Linden Capital Partners Acquires Alcresta Therapeutics

March 12, 2024

Medical Devices

Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.

Leonard Green & Partners Leads Recapitalization of WCG with Arsenal and Novo Holdings

November 14, 2019

Healthcare Services

An investor group led by Leonard Green & Partners, in partnership with Arsenal Capital Partners and Novo Holdings A/S, has agreed to recapitalize WCG to provide resources to accelerate growth and expand capabilities in clinical trial optimization. Financial terms were not disclosed; the transaction was announced in November 2019 and expected to close in the first quarter of 2020.